Experimental Treatment May Extend Leukemia Survival
One of the challenges of leukemia is that it likes to return. Once the blood cancer comes back, it’s more difficult to treat and beat. Medical scientists are experimenting with a way to boost the body’s immune system to get in on the fight and win.
Keeping Track of CML
Staying on top of a chronic disease is key to staying well. Managing these diseases can be tricky. Chronic myeloid leukemia (CML) is a great example.
Cancer Risks of Cancer Treatment
You do what you can – what you’re told – to beat the cancer. Chemotherapy is recommended and it works. Years later, though, you’re diagnosed with a blood cancer that could be related to the chemotherapy. Is this really happening?
Cancer Rx Granted Accelerated FDA Approval Path
The US Food and Drug Administration has given ibrutinib an accelerated pathway to approval. Ibrutinib is an investigational drug designed to treat two lymphomas.
Living With Chronic Myeloid Leukemia
People diagnosed with chronic myeloid leukemia (CML) are living longer than ever before. A number of effective therapies are available for all phases of the disease, but living with CML has its challenges.
Finding the Path of No Return for Kids with Cancer
The cure rate for one type of blood cancer that affects children - acute lymphoblastic leukemia (ALL) – is now about 80 percent. For the remaining 20 percent of kids who develop the disease, the outlook can be dire.
New Rx for Advanced Multiple Myeloma
Multiple myeloma is a blood cancer that affects nearly 22,000 Americans every year. It develops in mostly older people when plasma cells in the bone marrow grow out of control.
Paradigm Shift - Healthy vs. Cancerous Cells
If you focus on maintaining a healthy lifestyle, you’re less likely to get sick. That’s simple logic. Researchers now think this approach might be an effective way to treat cancer.
A Combination Leukemia Can’t Take
Many patients with chronic lymphocytic leukemia do pretty well with standard treatment. The disease retreats and stays in remission. However, some patients aren’t so fortunate. A new combination may be just what these patients need.
Children With Leukemia Have New Rx
Acute lymphoblastic leukemia (ALL) is the most common blood cancer found in children. It’s diagnosed in nearly 3,000 children in the United States every year and can progress quickly if left untreated. These kids now have a new treatment option.